Scotia Capital Inc. Xenon Pharmaceuticals Inc. Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$33.06 - $39.43 $244,379 - $291,466	-7,392 Reduced 21.58%	26,859 $1.06 Million
Q3 2022 Nov 10, 2022	SELL	$30.79 - $39.82 $99,236 - $128,339	-3,223 Reduced 8.6%	34,251 $1.24 Million
Q2 2022 Aug 05, 2022	BUY	$25.44 - $35.16 $82,883 - $114,551	3,258 Added 9.52%	37,474 $1.14 Million
Q1 2022 May 09, 2022	BUY	$25.09 - $33.13 $13,046 - $17,227	520 Added 1.54%	34,216 $1.05 Million
Q4 2021 Feb 11, 2022	SELL	$15.6 - $35.4 $53,664 - $121,776	-3,440 Reduced 9.26%	33,696 $1.05 Million
Q3 2021 Nov 12, 2021	SELL	$14.86 - $19.45 $42,811 - $56,035	-2,881 Reduced 7.2%	37,136 $567,000
Q2 2021 Aug 12, 2021	SELL	$16.81 - $20.0 $18,827 - $22,400	-1,120 Reduced 2.72%	40,017 $745,000
Q1 2021 May 06, 2021	BUY	$13.65 - $21.31 $3,276 - $5,114	240 Added 0.59%	41,137 $736,000
Q4 2020 Feb 11, 2021	SELL	$9.49 - $16.04 $7,943 - $13,425	-837 Reduced 2.01%	40,897 $629,000
Q3 2020 Nov 12, 2020	BUY	$10.82 - $13.35 $1,806 - $2,229	167 Added 0.4%	41,734 $462,000
Q2 2020 Aug 11, 2020	BUY	$10.21 - $14.9 $214 - $312	21 Added 0.05%	41,567 $522,000
Q1 2020 May 15, 2020	SELL	$8.08 - $17.57 $169,381 - $368,319	-20,963 Reduced 33.54%	41,546 $471,000
Q4 2019 Feb 13, 2020	SELL	$8.11 - $14.65 $30,809 - $55,655	-3,799 Reduced 5.73%	62,509 $820,000
Q3 2019 Nov 14, 2019	SELL	$8.74 - $10.51 $5,497 - $6,610	-629 Reduced 0.94%	66,308 $597,000
Q2 2019 Aug 13, 2019	SELL	$8.51 - $10.75 $1,233 - $1,558	-145 Reduced 0.22%	66,937 $660,000
Q1 2019 May 15, 2019	BUY	$6.39 - $10.42 $2,415 - $3,938	378 Added 0.57%	67,082 $682,000
Q4 2018 Feb 11, 2019	BUY	$5.61 - $12.62 $53,956 - $121,379	9,618 Added 16.85%	66,704 $421,000
Q3 2018 Nov 14, 2018	SELL	$9.0 - $14.9 $65,439 - $108,337	-7,271 Reduced 11.3%	57,086 $754,000
Q1 2018 May 15, 2018	BUY	$2.7 - $4.9 $3,885 - $7,051	1,439 Added 2.29%	64,357 $315,000
Q4 2017 Feb 13, 2018	BUY	$2.2 - $3.25 $18,803 - $27,777	8,547 Added 15.72%	62,918 $178,000
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.25 $45,917 - $60,911	18,742 Added 52.6%	54,371 $160,000
Q2 2017 Aug 15, 2017	BUY	N/A	35,629	35,629 $112,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

Avoro Capital Advisors LLC New York, NY

5.67M
Shares

$217 Million
3.36% of portfolio
Driehaus Capital Management LLC Chicago, IL

4.6M
Shares

$176 Million
1.77% of portfolio
Wellington Management Group LLP Boston, MA

3.84M
Shares

$147 Million
0.03% of portfolio
Braidwell LP Stamford, CT

2.71M
Shares

$104 Million
3.02% of portfolio
Commodore Capital LP New York, NY

2.7M
Shares

$103 Million
9.03% of portfolio

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account